Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer

NCT01891708 is registered in ClinicalTrials.gov with Li Liu as lead sponsor.

NCT NCT01891708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01891708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
VEGFRs Predict Bevacizumab Benefit in Advanced Non Small Cell Lung Cancer
Lead sponsor
Li Liu
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2013
Completion date
December 31, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastasis, non small cell lung cancer